Hyperfractionated or accelerated radiotherapy in lung cancer: an individual patient data meta-analysis. - Wikidata - awgldk - TriplyDB

Hyperfractionated or accelerated radiotherapy in lung cancer: an individual patient data meta-analysis.

Hyperfractionated or accelerated radiotherapy in lung cancer: an individual patient data meta-analysis.

http://www.wikidata.org/entity/Q34323959

about

Advances in dosimetry and biological predictors of radiation-induced esophagitis Combining targeted agents and hypo- and hyper-fractionated radiotherapy in NSCLC Innovative technologies in thoracic radiation therapy for lung cancer 2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer Definitive radiotherapy in locally advanced non-small cell lung cancer: dose and fractionation Challenges in the treatment of early non-small cell lung cancer: what is the standard, what are the challenges and what is the future for radiotherapy?Impact of thoracic radiotherapy timing in limited-stage small-cell lung cancer: usefulness of the individual patient data meta-analysis.Radiation Therapy Intensification for Solid Tumors: A Systematic Review of Randomized Trials Accelerated fraction radiotherapy with capecitabine as neoadjuvant therapy for borderline resectable pancreatic cancer.Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients' data.Difference in Restricted Mean Survival Time for Cost-Effectiveness Analysis Using Individual Patient Data Meta-Analysis: Evidence from a Case Study.Accelerated or hyperfractionated radiotherapy for esophageal carcinoma: a meta-analysis of randomized controlled trials A phase I study of concurrent individualized, isotoxic accelerated radiotherapy and cisplatin-vinorelbine-cetuximab in patients with stage III non-small-cell lung cancer.A pattern of early radiation-induced inflammatory cytokine expression is associated with lung toxicity in patients with non-small cell lung cancer.Neoadjuvant radiotherapy/chemoradiotherapy in locally advanced non-small cell lung cancer.Who benefits from hypofractionated radiation therapy for clinically localized prostate cancer: evidence from meta-analysis.Accelerated radiotherapy and concurrent chemotherapy for patients with contralateral central or mediastinal lung cancer relapse after pneumonectomy Radiation dose is associated with prognosis of small cell lung cancer with superior vena cava syndrome.Normal tissue complication models for clinically relevant acute esophagitis (≥ grade 2) in patients treated with dose differentiated accelerated radiotherapy (DART-bid).Comparison of once daily radiotherapy to 60 Gy and twice daily radiotherapy to 45 Gy for limited stage small-cell lung cancer DART-bid (Dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily)--a novel approach for non-resected NSCLC: final results of a prospective study, correlating radiation dose to tumor volume.Management of normal tissue toxicity associated with chemoradiation (primary skin, esophagus, and lung).The addition of amifostine to carboplatin and paclitaxel based chemoradiation in locally advanced non-small cell lung cancer: long-term follow-up of Radiation Therapy Oncology Group (RTOG) randomized trial 9801.Phase III study of cisplatin with pemtrexed or vinorelbine plus concurrent late course accelerated hyperfractionated radiotherapy in patients with unresectable stage III non-small cell lung cancer.IDEAL-CRT: A Phase 1/2 Trial of Isotoxic Dose-Escalated Radiation Therapy and Concurrent Chemotherapy in Patients With Stage II/III Non-Small Cell Lung Cancer.Moderately Escalated Hypofractionated (Chemo) Radiotherapy Delivered with Helical Intensity-Modulated Technique in Stage III Unresectable Non-Small Cell Lung Cancer.Progress in the management of limited-stage small cell lung cancer.Therapeutic management options for stage III non-small cell lung cancer.Hyperfractionated and accelerated radiotherapy in non-small cell lung cancer.Comparison of once and twice daily radiotherapy for limited stage small-cell lung cancer.The circadian timing system in clinical oncology.PET in the management of locally advanced and metastatic NSCLC.Radiotherapy in patients with pacemakers and implantable cardioverter defibrillators: a literature review.Emerging Role of MRI for Radiation Treatment Planning in Lung Cancer.Pathways to improving combined modality therapy for stage III nonsmall-cell lung cancer.Exploiting Gene Expression Kinetics in Conventional Radiotherapy, Hyperfractionation, and Hypofractionation for Targeted Therapy.Long-Term Results of a Trial of Concurrent Chemotherapy and Escalating Doses of Radiation for Unresectable Non-Small Cell Lung Cancer: NCCTG N0028 (Alliance).From chemotherapy to target therapies associated with radiation in the treatment of NSCLC: a durable marriage?Dose and Fractionation in Radiation Therapy of Curative Intent for Non-Small Cell Lung Cancer: Meta-Analysis of Randomized Trials.A population-based comparative effectiveness study of chemoradiation regimens and sequences in stage III non-small cell lung cancer.

P2860

Q26766530-6CBA0BB9-60C9-48D0-AF7A-A37BB2636157 Q26852202-22975574-E4BD-4B1E-BF29-9C4B3ECECBF9 Q26863239-43271396-7DB0-414E-9B5E-6EE9FDB7FFBE Q27002509-024F1E0E-2362-4D06-ADFC-1ECDF3A1BEE4 Q27027626-EC5260D8-2022-4BD1-B766-2C4D80D0438F Q28083924-556DAA4F-C3C3-4798-A148-6B5BFA9A9091 Q30248898-2C7739BD-EEAB-4759-9B58-9EFF74851CCE Q30278410-63427AB6-DD3C-487D-8DD3-5C890990A7CB Q30414737-51E2CA2F-D913-4AAF-AD08-A328AED0D01B Q30627447-993FE402-08B9-4D06-A076-1E8807A4F5A1 Q31056094-9945450F-5C4C-405F-8AF6-2694BCB5E6F7 Q33813067-D0450B6D-FE57-4B0A-8674-398203CFC8A7 Q34041735-8D2D2CFD-4645-48D6-9D22-571A34A8F296 Q34302308-B5BD2F1F-2FC5-4A96-99A8-39BE5AFA4FD0 Q35125456-318D8724-B503-4A6A-8321-5D69A5B40CB6 Q35201788-0CA8855E-2B9E-42A6-AE8D-8E7BAB719208 Q35290831-C0EE14BA-E54A-4A3A-9F3C-6C487A5E14D0 Q35643997-136C97DA-24C1-416D-AC94-5E9E7C429827 Q35669846-E9492D2A-4447-4C58-ACEC-6888CBB1728C Q36051734-34F8C52F-6253-4557-8D6C-D3BE07EFD750 Q36710620-F8CE39E3-3F82-44A9-9807-309AB2B87BD7 Q36811458-E0C88BE2-E780-4272-977D-A311B92B8636 Q36823982-6B7EE064-E72A-464F-80E6-9708B4D58139 Q36946823-035CAD5E-ED02-4535-8606-9302E33B2853 Q37123650-3F865CF1-6C0C-4EDA-9858-E13E42D778FB Q37317610-B1BBFA00-113E-4CA4-8317-B17D8614267D Q37626969-8F9C1712-C8EB-4260-BBA5-35103D957220 Q37642455-49C88CDC-D450-4545-941D-DC46AFB761A9 Q37670429-D1901358-DF7D-431B-B4A0-E7B8CCFBB271 Q38155779-847D2003-1D56-4A71-8ABD-20726C81D58A Q38219193-09900832-2B6A-4962-847F-5AC008FCC767 Q38444980-D17F92D2-2443-443D-9F47-4E32CB620862 Q38515251-5D24F3A6-6116-4121-956B-E3111492C7D8 Q38641099-B2AE8284-8C99-4921-8651-45631B99845F Q38682031-4E0F8216-7483-430A-A1E4-7A97E0668B75 Q38952268-D186DA1F-2DB8-4FC3-AB4D-561265C4CAD1 Q39019487-5529C254-7381-431E-A3B8-E663EED67861 Q39041541-C71F9DC9-97C5-463B-9943-14177733FA25 Q39378862-D60DEC66-3117-46B2-8E7C-42EB6BD5DF98 Q40155605-70734471-59BD-453C-B436-40D15FAB47D3

P2860

Hyperfractionated or accelerated radiotherapy in lung cancer: an individual patient data meta-analysis.

http://www.wikidata.org/entity/Q34323959

description

2012 nî lūn-bûn

@nan

2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Hyperfractionated or accelerat ...... al patient data meta-analysis.

@ast

Hyperfractionated or accelerat ...... al patient data meta-analysis.

@en

Hyperfractionated or accelerat ...... al patient data meta-analysis.

@nl

type

label

Hyperfractionated or accelerat ...... al patient data meta-analysis.

@ast

Hyperfractionated or accelerat ...... al patient data meta-analysis.

@en

Hyperfractionated or accelerat ...... al patient data meta-analysis.

@nl

prefLabel

Hyperfractionated or accelerat ...... al patient data meta-analysis.

@ast

Hyperfractionated or accelerat ...... al patient data meta-analysis.

@en

Hyperfractionated or accelerat ...... al patient data meta-analysis.

@nl

P1433

Q34323959-63F61E84-5DC3-47F2-9AA8-6F2376D2B55E

P1476

Q34323959-5E051453-4441-4445-BF68-C2F53237D2B5

P2093

Q34323959-156CA380-FAB0-4980-B5F2-8C653CE406D1

Q34323959-27D74592-ADED-418F-9386-01951AB13026

Q34323959-307E3490-7B30-4922-90E8-1D9D2B9B17D2

Q34323959-30E8BE51-2402-4D6E-BBDF-8518026827EB

Q34323959-42BDFC8D-11AF-4D83-A468-C955A266D751

Q34323959-5DEA6F1F-E0C8-4A23-B21E-74E89E6A36FA

Q34323959-63EB5769-F4E0-4D25-AFDB-EEDF6E6BCD43

Q34323959-7D52744C-7CAC-46A8-B418-B8AF1E1AFD09

Q34323959-CC738343-7A42-4EB3-91C8-3571E3FED107

Q34323959-D3031C35-6786-42E5-8798-82CDCAFA9676

P2860

Q34323959-06E1FDF7-443C-4707-A70D-A663624DA8F4

Q34323959-0C929EF6-FD6A-42A9-B2B8-12D47A7D3511

Q34323959-106BE493-F7A6-4D48-86F6-DD5A376ECB91

Q34323959-1540699D-E175-44E7-B592-7A6B89A63E83

Q34323959-175C16DE-CECB-406C-A96F-019598A7A9D1

Q34323959-1A017C44-B9F8-4E40-8019-5552F0A4BD56

Q34323959-373684F2-4547-4A8B-87A0-3F1C4463E9EA

Q34323959-3B47EB9E-7B88-4916-95BA-B4B4EE19D33D

Q34323959-41269D93-DB1F-4FD4-AF9F-9AC45BCD085D

Q34323959-45EBCDF0-8236-4BD6-B851-61563F257931

P304

Q34323959-ED096651-8A55-4581-92B2-7F47FFADAA7C

P31

Q34323959-82b91a9f-2421-4de6-a3fc-99773b4eb78c

Q34323959-DBD66EC4-A76E-4C05-9C2C-964157F2845E

P356

Q34323959-BD9EE2B3-E4CC-45AF-9830-79BF9D229F7E

P407

Q34323959-CFD3A94A-B272-4DEC-A66F-AB00B5D45599

P433

Q34323959-E6AFF470-CC9E-4026-9919-A75AFF488A73

P478

Q34323959-8739C211-E803-4D69-A7B7-479F0D1928AB

P50

Q34323959-166CAC5E-1F18-498D-B3F6-A392CF9D23B1

Q34323959-3B9696CB-B5EC-47E5-97FE-6201E3E93000

Q34323959-40E5AD29-E777-4305-BC30-D7AC5CC881B0

Q34323959-60E08B0A-F769-4EF0-A997-85967AA47054

Q34323959-70F50786-96BD-4C7D-9A39-7EBBFB99E76F

Q34323959-8EBD694E-53AD-4116-AB1B-686E6F886EC6

Q34323959-943C7CB4-4F46-472E-8615-A20CC35CCF59

Q34323959-DF7B61C8-F256-4A38-8B81-5474F31B38C3

Q34323959-EC235D65-1396-4A02-A286-56A689485768

P577

Q34323959-28EC999E-5782-46E8-A43A-82A61DD4CB63

P698

Q34323959-58045AFC-F250-4470-9394-D988B8B98860

P921

Q34323959-1EFFE551-75EF-4062-9791-6E64745D31DA

Q34323959-8566D402-855A-4E41-950A-B854EC69FD26

Q34323959-9C783E11-026D-43F6-A0C7-5786D88DDF76

P932

Q34323959-721F8983-C374-4637-91E1-56FFF4DB46E2

P356

JCO.2012.41.6677

P1433

Journal of Clinical Oncology

P1476

Hyperfractionated or accelerat ...... al patient data meta-analysis.

@en

P2093

Andrew T Turrisi

http://www.w3.org/2001/XMLSchema#string

Cécile Le Péchoux

http://www.w3.org/2001/XMLSchema#string

David Ball

http://www.w3.org/2001/XMLSchema#string

James A Bonner

http://www.w3.org/2001/XMLSchema#string

James F Bishop

http://www.w3.org/2001/XMLSchema#string

Katarzyna Behrendt

http://www.w3.org/2001/XMLSchema#string

Matthew Nankivell

http://www.w3.org/2001/XMLSchema#string

Michele I Saunders

http://www.w3.org/2001/XMLSchema#string

Rainer Koch

http://www.w3.org/2001/XMLSchema#string

Rebecca Paulus

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics, 2002

Quantifying heterogeneity in a meta-analysis

Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. CHART Steering committee.

Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data.

Phase III trial comparing chemotherapy plus once-daily or twice-daily radiotherapy in Stage III non-small-cell lung cancer.

A critical review of methods for the assessment of patient-level interactions in individual participant data meta-analysis of randomized trials, and guidance for practitioners.

Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group.

Meta-analysis of the literature or of individual patient data: is there a difference?

Beta blockade during and after myocardial infarction: an overview of the randomized trials.

Radiation dose escalation in non-small cell carcinoma of the lung.

P304

2788-2797

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2012.41.6677

http://www.w3.org/2001/XMLSchema#string

P407

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P50

Rodrigo Arriagada

Steven E Schild

Jean-Pierre Pignon

Suzanne E Dahlberg

Aleksander Zajusz

Michael Baumann

Dirk De Ruysscher

P577

2012-07-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22753901

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

4934452

http://www.w3.org/2001/XMLSchema#string